Association between BRAF V600E mutation and ultrasound features in papillary thyroid carcinoma patients with and without hashimoto's thyroiditis
Q Zhang, BJ Liu, WW Ren, YP He, XL Li, CK Zhao… - Scientific reports, 2017 - nature.com
To assess the association between BRAF V600E mutation and ultrasound (US) features in
papillary thyroid carcinoma (PTC) patients with and without Hashimoto's thyroiditis (HT). We …
papillary thyroid carcinoma (PTC) patients with and without Hashimoto's thyroiditis (HT). We …
[PDF][PDF] RETRACTED ARTICLE: microRNA-564 inhibits the aggressive phenotypes of papillary thyroid cancer by directly targeting astrocyte-elevated gene-1
Z Song, H Yang, X Wu, C Kong, C Xu - OncoTargets and therapy, 2019 - Taylor & Francis
Song Z, Yang H, Wu X, Kong C, Xu C. Onco Targets Ther. 2019; 12: 4869–4881. The Editor
and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns …
and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns …
Interactions of vascular endothelial growth factor and p53 with miR-195 in thyroid carcinoma: possible therapeutic targets in aggressive thyroid cancers
Background: The clinical pathological features, as well as the cellular mechanisms of miR-
195, have not been investigated in thyroid carcinoma. Objective: The aim of this study is to …
195, have not been investigated in thyroid carcinoma. Objective: The aim of this study is to …
Prognostic implications of CD10 and CD15 expression in papillary thyroid carcinoma
Patients with papillary thyroid carcinoma (PTC) have excellent survival, but recurrence
remains a major problem in the management of PTC. We aimed to determine the prognostic …
remains a major problem in the management of PTC. We aimed to determine the prognostic …
ZCCHC12, a novel oncogene in papillary thyroid cancer
O Wang, Z Zheng, Q Wang, Y Jin, W Jin… - Journal of Cancer …, 2017 - Springer
Purpose Thyroid cancer is the most common endocrine malignancy worldwide. The
molecular mechanisms underlying thyroid tumorigenesis remain unclear. Some studies …
molecular mechanisms underlying thyroid tumorigenesis remain unclear. Some studies …
Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases
J Zhi, J Zhao, M Gao, Y Pan, J Wu, Y Li, D Li… - International journal of …, 2018 - Springer
Background The incidence of papillary thyroid microcarcinoma (PTMC) has been increasing
globally in the past few decades. PTMC does not have a distinctive morphology that results …
globally in the past few decades. PTMC does not have a distinctive morphology that results …
Identification of two distinct molecular subtypes of non-invasive follicular neoplasm with papillary-like nuclear features by digital RNA counting
R Giannini, C Ugolini, AM Poma, M Urpi, C Niccoli… - Thyroid, 2017 - liebertpub.com
Background: The follicular variant (FV) of papillary thyroid cancer (PTC) is one of the most
common variants of PTC. Clinically, non-infiltrative FVPTC is considered a low-risk variant of …
common variants of PTC. Clinically, non-infiltrative FVPTC is considered a low-risk variant of …
Gene expression patterns unveil new insights in papillary thyroid cancer
Background and objectives: Papillary thyroid carcinoma is the most frequent variety of all
malignant endocrine tumors. It represents a heterogeneous malignancy with various clinical …
malignant endocrine tumors. It represents a heterogeneous malignancy with various clinical …
Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age
R Villar‑Taibo, D Peteiro‑González… - Oncology …, 2017 - spandidos-publications.com
The tall cell variant (TCV) of papillary thyroid carcinoma (PTC) is characterized by tall
columnar cells with a height of at least three times their width. TCV usually presents at an …
columnar cells with a height of at least three times their width. TCV usually presents at an …
Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma
F Xia, B Jiang, Y Chen, X Du, Y Peng, W Wang… - Medicine, 2018 - journals.lww.com
Background: Tall cell variant papillary thyroid carcinoma (TCPTC) is reportedly associated
with aggressive clinicopathological parameters and poor outcomes; however, the molecular …
with aggressive clinicopathological parameters and poor outcomes; however, the molecular …